Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...

Eli Lilly is investing $6B in a Huntsville, Ala., plant to make weight-loss and other medicines. Here’s what we know about ...

James Corden admitted he ditched Ozempic last year after it failed to curb his eating habits - but his lookalike sister, Ruth ...

Eli Lilly to invest $6 billion in new synthetic medicine facility in Huntsville, AL to boost domestic production and create ...

CNN’s Erin Burnett talks to Eli Lilly CEO David Ricks about the company’s anticipated weight loss pill, its affordability, and the potential jobs created from a new $6 billion U.S. factory.

Eli Lilly surged into a rarefied tier of corporate giants on November 21, becoming the first pharmaceutical company in history to reach a US$1 trillion market valuation This milestone has been driven ...

The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...

The explosive rise of drugs like Ozempic and Mounjaro is shifting consumption patterns, health outcomes and pushing ...

The singer and actress has lost more than 60Ibs through a combination of regular exercise, dietary tweaks and low doses of ...

An experimental medication was shown to help boost weight loss by up to 20%, a study found. Eloralintide, a once-weekly injectable manufactured by Eli Lilly in Indianapolis, led to "meaningful, ...

Eli Lilly and Novo Nordisk are collaborating with Waltz Health to launch direct-to-employer access for obesity management medications. Waltz Health gave no information on the prices of GLP-1 drugs ...